Eckelman Brendan P.

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 59% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Eckelman Brendan P.'s trades of Inhibrx Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-05-30 2024-05-28
US Inhibrx Inc (INBX)
S Sale
99,739 -11.5%
156.15
US$2,972,701 		99,739 -11.5% 156.15 US$2,972,701
2024-05-28 2024-05-28
US Inhibrx Inc (INBX)
PrS Proposed sale
60,550
311.13
US$1,482,791 		60,550 311.13 US$1,482,791
2024-05-22 2024-05-22
US Inhibrx Inc (INBX)
PrS Proposed sale
38,185
294.43
US$860,179 		38,185 294.43 US$860,179
2024-03-13 2024-03-13
US Inhibrx Inc (INBX)
PrS Proposed sale
1,898
35.33
US$67,062 		1,898 35.33 US$67,062
2024-03-12 2024-03-12
US Inhibrx Inc (INBX)
PrS Proposed sale
24,050
35.25
US$847,856 		24,050 35.25 US$847,856
2024-03-11 2024-03-11
US Inhibrx Inc (INBX)
PrS Proposed sale
13,558
35.32
US$478,827 		13,558 35.32 US$478,827
2024-03-08 2024-03-08
US Inhibrx Inc (INBX)
PrS Proposed sale
2,150
35.75
US$76,862 		2,150 35.75 US$76,862
2023-03-02 2023-03-01
US Inhibrx Inc (INBX)
PlS Planned sale
400 -0.0%
24.71
US$9,883 		400 -0.0% 24.71 US$9,883
2023-03-02 2023-03-01
US Inhibrx Inc (INBX)
PlS Planned sale
39,600 -1.9%
24.20
US$958,348 		39,600 -1.9% 24.20 US$958,348
2023-02-02 2023-02-02
US Inhibrx Inc (INBX)
PlS Planned sale
1,130 -0.1%
25.89
US$29,261 		1,130 -0.1% 25.89 US$29,261
2023-02-02 2023-02-02
US Inhibrx Inc (INBX)
PlS Planned sale
10,120 -0.5%
25.40
US$257,094 		10,120 -0.5% 25.40 US$257,094
2023-02-02 2023-02-01
US Inhibrx Inc (INBX)
PlS Planned sale
693 -0.0%
25.66
US$17,780 		693 -0.0% 25.66 US$17,780
2023-02-02 2023-02-01
US Inhibrx Inc (INBX)
PlS Planned sale
14,608 -0.7%
25.08
US$366,366 		14,608 -0.7% 25.08 US$366,366
2023-02-02 2023-02-01
US Inhibrx Inc (INBX)
PlS Planned sale
13,449 -0.6%
24.29
US$326,710 		13,449 -0.6% 24.29 US$326,710
2023-01-04 2023-01-04
US Inhibrx Inc (INBX)
PlS Planned sale
3,003 -0.1%
23.99
US$72,043 		3,003 -0.1% 23.99 US$72,043
2023-01-04 2023-01-04
US Inhibrx Inc (INBX)
PlS Planned sale
4,102 -0.2%
23.11
US$94,786 		4,102 -0.2% 23.11 US$94,786
2023-01-04 2023-01-03
US Inhibrx Inc (INBX)
PlS Planned sale
2,084 -0.1%
25.09
US$52,293 		2,084 -0.1% 25.09 US$52,293
2023-01-04 2023-01-03
US Inhibrx Inc (INBX)
PlS Planned sale
8,598 -0.4%
24.36
US$209,426 		8,598 -0.4% 24.36 US$209,426
2023-01-04 2023-01-03
US Inhibrx Inc (INBX)
PlS Planned sale
22,213 -1.0%
23.41
US$520,051 		22,213 -1.0% 23.41 US$520,051
2022-12-07 2022-12-06
US Inhibrx Inc (INBX)
PlS Planned sale
1,392 -0.1%
28.46
US$39,617 		1,392 -0.1% 28.46 US$39,617
2022-12-07 2022-12-06
US Inhibrx Inc (INBX)
PlS Planned sale
17,681 -0.8%
27.57
US$487,493 		17,681 -0.8% 27.57 US$487,493
2022-12-07 2022-12-06
US Inhibrx Inc (INBX)
PlS Planned sale
20,927 -1.0%
26.83
US$561,572 		20,927 -1.0% 26.83 US$561,572
2022-11-02 2022-11-01
US Inhibrx Inc (INBX)
PlS Planned sale
12,349 -0.6%
33.90
US$418,641 		12,349 -0.6% 33.90 US$418,641
2022-11-02 2022-11-01
US Inhibrx Inc (INBX)
PlS Planned sale
27,651 -1.2%
33.34
US$921,746 		27,651 -1.2% 33.34 US$921,746
2022-10-05 2022-10-04
US Inhibrx Inc (INBX)
PlS Planned sale
100 -0.0%
30.52
US$3,052 		100 -0.0% 30.52 US$3,052
2022-10-05 2022-10-04
US Inhibrx Inc (INBX)
PlS Planned sale
10,893 -0.5%
29.68
US$323,302 		10,893 -0.5% 29.68 US$323,302
2022-10-05 2022-10-04
US Inhibrx Inc (INBX)
PlS Planned sale
5,954 -0.3%
28.97
US$172,495 		5,954 -0.3% 28.97 US$172,495
2022-10-05 2022-10-04
US Inhibrx Inc (INBX)
PlS Planned sale
4,262 -0.2%
27.76
US$118,299 		4,262 -0.2% 27.76 US$118,299
2022-10-05 2022-10-04
US Inhibrx Inc (INBX)
PlS Planned sale
11,136 -0.5%
26.78
US$298,182 		11,136 -0.5% 26.78 US$298,182
2022-10-05 2022-10-04
US Inhibrx Inc (INBX)
PlS Planned sale
6,207 -0.3%
26.06
US$161,763 		6,207 -0.3% 26.06 US$161,763
2022-10-05 2022-10-04
US Inhibrx Inc (INBX)
PlS Planned sale
1,448 -0.1%
24.67
US$35,720 		1,448 -0.1% 24.67 US$35,720
2022-09-07 2022-09-06
US Inhibrx Inc (INBX)
PlS Planned sale
2,493 -0.1%
15.66
US$39,032 		2,493 -0.1% 15.66 US$39,032
2022-09-07 2022-09-06
US Inhibrx Inc (INBX)
PlS Planned sale
37,507 -1.5%
14.86
US$557,241 		37,507 -1.5% 14.86 US$557,241
2022-08-04 2022-08-03
US Inhibrx Inc (INBX)
PlS Planned sale
15,500 -0.6%
18.47
US$286,209 		15,500 -0.6% 18.47 US$286,209
2022-08-04 2022-08-02
US Inhibrx Inc (INBX)
PlS Planned sale
24,500 -1.0%
17.70
US$433,626 		24,500 -1.0% 17.70 US$433,626
2022-07-08 2022-07-07
US Inhibrx Inc (INBX)
PlS Planned sale
40,000 -1.6%
17.17
US$686,800 		40,000 -1.6% 17.17 US$686,800
2022-04-07 2022-04-05
US Inhibrx Inc (INBX)
PlS Planned sale
400 -0.0%
25.04
US$10,016 		400 -0.0% 25.04 US$10,016
2021-03-24 2021-03-24
US Inhibrx Inc (INBX)
PlS Planned sale
17,000 -0.7%
19.02
US$323,340 		17,000 -0.7% 19.02 US$323,340
2021-02-18 2021-02-16
US Inhibrx Inc (INBX)
PlS Planned sale
17,000 -0.7%
25.90
US$440,300 		17,000 -0.7% 25.90 US$440,300